Showing results (2951-2960 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1990
Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancerT Umsawasdi, T B Felder, D Jeffries, et al.Investigational New Drugs|June 28, 2011
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression statusMyoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, et al.Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.Investigational New Drugs|June 1, 2011
Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Ron J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.Investigational New Drugs|November 1, 1989
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group studyW P McGuire, J A Blessing, M L BermanInvestigational New Drugs|September 19, 2015
Blinatumomab for the treatment of acute lymphoblastic leukemiaJason B Kaplan, Marina Grischenko, Francis J GilesInvestigational New Drugs|September 21, 2015
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patientsJ M Baas, L L Krens, A J ten Tije, et al.Investigational New Drugs|December 31, 2015
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancersElizabeth R Kessler, S Gail Eckhardt, Todd M Pitts, et al.Investigational New Drugs|January 19, 2016
Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549Izabella Thaís Silva, Fabiana Cristina Geller, Lara Persich, et al.Pageof 372